Skip to content

Asymmetric dimethylarginine is associated with the phenomenon of slow coronary blood flow in patients with atrial fibrillation

Asymmetric dimethylarginine is associated with the phenomenon of slow coronary blood flow in patients with atrial fibrillation

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300074074
Enrollment
Unknown
Registered
2023-07-28
Start date
2023-07-28
Completion date
Unknown
Last updated
2023-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial fibrillation, angina pectoris

Interventions

Normal coronary angiography group/Atrial fibrillation with normal coronary angiography group/Atrial fibrillation with coronary angiography slow flow group:N/A

Sponsors

Qingdao Municipal Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Coronary artery stenosis<50%. (2) No invasive treatment such as coronary stent implantation or balloon angioplasty has been performed.

Exclusion criteria

Exclusion criteria: 1. Patients with valve diseases (rheumatic heart disease, heart valve replacement or repair, moderate to severe mitral valve or Aortic valve regurgitation or stenosis). 2. There have been acute cardiovascular and cerebrovascular events (such as acute myocardial infarction, congestive heart failure or stroke), unstable angina, history of malignant tumor, liver disease, chronic kidney disease, Thyroid disease, pregnancy and active infection within one month. 3. Coronary angiography shows complete or>50% occlusion of the coronary artery, after coronary stent implantation or balloon angioplasty. 4. Previous myocardial revascularization, coronary artery bypass graft, left ventricular Ejection fraction<40%.

Design outcomes

Primary

MeasureTime frame
ADMA;

Secondary

MeasureTime frame
NO;p-sel;PAI-1;vWF;D-Di;

Countries

China

Contacts

Public ContactWei XIA

Qingdao Municipal Hospital

summer0419@163.com+86 186 6971 0958

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026